Literature DB >> 12006146

Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.

Joan Serra-Batlles1, Vicente Plaza, Carlos Badiola, Elena Morejón.   

Abstract

This study was designed to provide information on correct use and preference to features and device handling of two multidose dry powder inhalers, the Diskus/Accuhaler and the Turbuhaler. A total of 169 powder-naive patients (mean age 40 years) with asthma or chronic obstructive pulmonary disease (COPD) were enrolled in a randomized crossover comparison of both inhalers. An effective use of either inhaler was assessed before (leaflet only) and after inhaler education. Ease of use especially during an attack and the presence of a dose counter were regarded as the most important features for an ideal inhaler. The percentage of correct handling maneuvers and the percentage of patients achieving 100% of correct maneuvers increased significantly (p < 0.001) after inhaler education in both devices, but percentage of correct use after the intervention was significantly higher for the Diskus/Accuhaler (92.6%) than for the Turbuhaler (89.8%; p = 0.036). Overall 60% of patients thought the Diskus/Accuhaler was preferable to the Turbuhaler (p < 0.001). The main reasons given were presence of a dose counter, perceived ease of use including ease of learning to use, design, and attached cover. Among those who preferred the Turbuhaler device, the main reason cited was small size, discreetness, and ease of holding. In the multivariate analysis, inhaler education (p = 0.005) and education level (p = 0.009) were significantly associated with the percentage of correct maneuvers. Age, sex, or tested inhaler showed no effect on appropriateness of the inhalation technique.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006146     DOI: 10.1089/08942680252908584

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  14 in total

1.  Exploring variables associated with medication non-adherence in patients with COPD.

Authors:  Anan S Jarab; Tareq L Mukattash
Journal:  Int J Clin Pharm       Date:  2019-08-30

Review 2.  Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).

Authors:  Sadia Janjua; Katharine C Pike; Robin Carr; Andy Coles; Rebecca Fortescue; Mitchell Batavia
Journal:  Cochrane Database Syst Rev       Date:  2021-09-08

3.  Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.

Authors:  Thomas Voshaar; Monica Spinola; Patrick Linnane; Alice Campanini; Daniel Lock; Anthony Lafratta; Mario Scuri; Barbara Ronca; Andrea S Melani
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

4.  Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence.

Authors:  Katherine Krauskopf; Alex D Federman; Minal S Kale; Keith M Sigel; Melissa Martynenko; Rachel O'Conor; Michael S Wolf; Howard Leventhal; Juan P Wisnivesky
Journal:  COPD       Date:  2014-06-24       Impact factor: 2.409

5.  Protocol for a feasibility randomized trial of self-management support for people with chronic obstructive pulmonary disease using lay health coaches.

Authors:  Alex D Federman; Michele Barry; Esther Moas; Claire Davenport; Christina McGeough; Marisilis Tejeda; Leny Rivera; Stacie Gutierrez; Hilda Mejias; Destini Belton; Cathleen Mathew; Peter K Lindenauer; Danielle McDermott; Rachel O'Conor; Michael S Wolf; Juan P Wisnivesky
Journal:  Contemp Clin Trials       Date:  2021-09-21       Impact factor: 2.226

6.  Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population.

Authors:  Sujeet K Rajan; Jaideep A Gogtay
Journal:  Lung India       Date:  2014-10

7.  A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.

Authors:  Job van der Palen; Mike Thomas; Henry Chrystyn; Raj K Sharma; Paul Dlpm van der Valk; Martijn Goosens; Tom Wilkinson; Carol Stonham; Anoop J Chauhan; Varsha Imber; Chang-Qing Zhu; Henrik Svedsater; Neil C Barnes
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-24       Impact factor: 2.871

Review 8.  Medication adherence issues in patients treated for COPD.

Authors:  Ruben D Restrepo; Melissa T Alvarez; Leonard D Wittnebel; Helen Sorenson; Richard Wettstein; David L Vines; Jennifer Sikkema-Ortiz; Donna D Gardner; Robert L Wilkins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  The Diskus: a review of its position among dry powder inhaler devices.

Authors:  H Chrystyn
Journal:  Int J Clin Pract       Date:  2007-06       Impact factor: 2.503

10.  Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.

Authors:  Eleftherios Zervas; Konstantinos Samitas; Mina Gaga
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.